The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) is the first national research institute in Germany focusing on biomedical research on human aging, a multifactorial process controlled by environmental and genetic factors.
This website will provide you with an insight into our institute, the research we do and the faces behind FLI's science activities. We wish you an exciting and entertaining voyage of discovery into the world of aging research at FLI.
FLI is now operating under conditions of Phase E
Due to the very low numbers of Corona infections nationwide and the progress in the vaccination campaign, the FLI has transited into Phase E of Covid-19 operations as of June 20, 2021.
In comparison to Phase D, Phase E allows further relaxations in the measures established - based on the federal emergency brake - which allows relaxations starting at an incidence value in Jena of 35 (number of infections per 100,000 population in the last 7 days).
Phase E loses its validity should the above-mentioned threshold value be exceeded again on at least three consecutive calendar days. In this case, the FLI guidelines of Phase D apply again.
If, however, virus variants should spread rapidly (e.g. variant delta), resulting in an increased risk of infection, this will be responded to immediately and, if necessary, the facilitations of Phase E will be withdrawn again.